查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
CRISPR遺傳基因檢測·診斷市場:研究，臨床檢驗，消費者，公共服務，其他 - 附執行顧問指南(2023年～2027年)
市場調查報告書
商品編碼
1345466

CRISPR遺傳基因檢測·診斷市場:研究，臨床檢驗，消費者，公共服務，其他 - 附執行顧問指南(2023年～2027年)

CRISPR Gene Detection and Diagnostic Markets by Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides. 2023 to 2027
出版日期: | 出版商: Howe Sound Research | 英文 417 Pages | 商品交期: 最快1-2個工作天內

價格

本報告提供全球CRISPR遺傳基因檢測·診斷市場相關調查，提供市場概要，以及各用途，生物趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 市場指南

第3章 市場概要

  • 市場進入組織
    • 學術研究機關
    • 診斷測試開發商
    • 儀器供應商
    • 藥品·試劑廠商
    • 病理供應商
    • 獨立型臨床檢驗室
    • 公共的國立/地區研究所
    • 醫院檢驗室
    • 臨床檢驗室
    • 審核機關
    • 認證機關
  • 遺傳物質檢測市場，案例及議論

第4章 市場趨勢

  • 成長促進因素
  • 阻礙成長的要素

第5章 最近的發展

第6章 主要企業

  • 10x Genomics, Inc.
  • Agilent/Dako
  • Axxam
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Binx Health
  • bioMérieux Diagnostics
  • Bio-Rad Laboratories, Inc.
  • Caspr Biotech
  • ERS Genomics
  • Illumina
  • Janssen Diagnostics
  • Locus Biosciences
  • Mammoth Biosciences
  • Myllia Biotechnology
  • Proof Diagnostics
  • Roche Molecular Diagnostics
  • Sherlock Biosciences
  • Thermo Fisher Scientific Inc.
  • Vivlion

第7章 全球CRISPR遺傳基因檢測·診斷市場

  • 全球市場概要，各國
  • 全球市場- 概要，各用途
  • 全球市場- 概要，生物

第8章 全球CRISPR遺傳基因檢測·診斷市場- 各用途

  • 研究
  • 臨床檢驗室
  • 臨床消費者
  • 公共服務
  • 農業·其他

第9章 全球CRISPR遺傳基因檢測·診斷市場- 生物

  • 人
  • 病原體
  • 其他

第10章 附錄

OVERVIEW:

CRISPR is not just about changing genes. CRISPR identifies unique genetic material instantly, accurately and cheaply. A whole new world of identification and diagnostics opens up. Find out exactly what kind of cold or flu you have. Find out exactly what kind of fish you are eating. Instantly detect the presence of unwelcome bacteria, anywhere.

Will this disruptive technology change the world of In Vitro Diagnostics? What is the impact on Clinical Laboratories? How will social norms be affected?

The market has just gotten started with a handful of small startup companies. Expect the big players to start taking notice. CRISPR is even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time. The report forecasts the market size looking out 5 years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. Methodology
    • 2.1.1. Methodology
    • 2.1.2. Sources
    • 2.1.3. Authors
  • 2.2. CRISPR Gene Detection Definition In This Report
    • 2.2.1. Research
    • 2.2.2. Clinical Laboratory
    • 2.2.3. Consumer Diagnostics
    • 2.2.4. Public Service
    • 2.2.5. Other
  • 2.3. CRISPR
    • 2.3.1. What is CRISPR?
    • 2.3.2. What is Gene Detection?
    • 2.3.3. The CRISPR Family
    • 2.3.4. Sensitivity of CRISPR
  • 2.4. Chromosomes, Genes and Epigenetics
    • 2.4.1. Chromosomes
    • 2.4.2. Genes
    • 2.4.3. Epigenetics
  • 2.5. Market Definition
    • 2.5.1. Revenue Market Size
  • 2.6. Perspective: Healthcare and the IVD Industry
    • 2.6.1. Global Healthcare Spending
    • 2.6.2. Spending on Diagnostics
    • 2.6.3. Important Role of Insurance for Diagnostics

3. Market Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Genetic Material Detection Markets, Examples and Discussion
    • 3.2.1. Research Markets
    • 3.2.2. Clinical Laboratories - Accuracy, Cost and Speed
      • 3.2.2.1. Multiplexing in the Lab and at the Point of Care
    • 3.2.3. Consumer Diagnostics
      • 3.2.3.1. The CRISPR Consumer
      • 3.2.3.2. Why Consumers Like Multiplexing
    • 3.2.4. Public Service Markets
      • 3.2.4.1. Public Health
      • 3.2.4.2. Public Security
      • 3.2.4.3. Environmental Monitoring
    • 3.2.5. AgriBio and Other Markets
      • 3.2.5.1. AgriBio

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. Cost, Accuracy and Speed
    • 4.1.2. The Economies of Multiplexing with Nucleic Acids
    • 4.1.3. The New Agriculture
    • 4.1.4. Pandemics and Pathogens
    • 4.1.5. Health and Self - A Sea Change in Healthcare
  • 4.2. Factors Limiting Growth
    • 4.2.1. Ubiquitous PCR
    • 4.2.2. The Shrinking Cost of All Things Genetic
    • 4.2.3. Wellness has a downside
    • 4.2.4. The Limits of Detection

5. CRISPR Recent Developments

  • 5.1. Recent Developments - Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. CrisprBits Collaborates With MolBio Diagnostics
  • 5.3. Sherlock Bioscience to Launch Free AI-Based Operating System
  • 5.4. Sherlock Biosciences to Acquire Sense Biodetection
  • 5.5. CRISPR Enzyme Discovery Opens Diagnostic Applications
  • 5.6. Sherlock Biosciences Adds Ambient Amplification to Diagnostic Toolkit
  • 5.7. Rice University Adapts CRISPR Enzyme to Create Ultra-Sensitive Test
  • 5.8. CRISPR-Based Tb Test Shows High Sensitivity
  • 5.9. Princeton Group Develops Cas13 Assay for Point-of-Care Use
  • 5.10. Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
  • 5.11. Sherlock Biosciences Raises $80M
  • 5.12. Broad Institute Considers CRISPR Respiratory Panels to Replace PCR
  • 5.13. Medix Biochemica Acquires MyPols Biotec
  • 5.14. Mammoth Biosciences High-Throughput CRISPR-Based COVID Test Gets EUA
  • 5.15. UCSD Developing At-Home Covid Test Leveraging CRISPR
  • 5.16. Genome Diagnostics Makes €1M Investment in CRISPR Dx Startup Scope Biosciences
  • 5.17. CRISPR SARS-CoV-2 Test Could be used for Asymptomatic Screening
  • 5.18. Mammoth Biosciences, Agilent to Comarket CRISPR-Based SARS-CoV-2 Test
  • 5.19. Pandemic Accelerates Development of CRISPR Diagnostics
  • 5.20. COVID Assays Use CRISPR and Smartphones
  • 5.21. ERS Genomics Licenses CRISPR Patents to Vivlion
  • 5.22. Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test
  • 5.23. ERS Genomics, FASMAC to Commercialize CRISPR-Cas9
  • 5.24. The Nobel Prize in Chemistry 2020 - CRISPR Wins
  • 5.25. Caspr Biotech Developing COVID Dx

6. Key Companies

  • 6.1. 10x Genomics, Inc.
  • 6.2. Agilent/Dako
  • 6.3. Axxam
  • 6.4. Beckman Coulter Diagnostics
  • 6.5. Becton, Dickinson and Company
  • 6.6. Binx Health
  • 6.7. bioMérieux Diagnostics
  • 6.8. Bio-Rad Laboratories, Inc.
  • 6.9. Caspr Biotech
  • 6.10. ERS Genomics
  • 6.11. Illumina
  • 6.12. Janssen Diagnostics
  • 6.13. Locus Biosciences
  • 6.14. Mammoth Biosciences
  • 6.15. Myllia Biotechnology
  • 6.16. Proof Diagnostics
  • 6.17. Roche Molecular Diagnostics
  • 6.18. Sherlock Biosciences
  • 6.19. Thermo Fisher Scientific Inc.
  • 6.20. Vivlion

7. The Global Market for CRISPR Gene Detection and Diagnostics

  • 7.1. Global Market Overview by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart-Global Market by Country
  • 7.2. Global Market by Application-Overview
    • 7.2.1. Table - Global Market by Application
    • 7.2.2. Chart - Global Market by Application - Base/Final Year Comparison
    • 7.2.3. Chart - Global Market by Application - Base Year
    • 7.2.4. Chart - Global Market by Application - Final Year
    • 7.2.5. Chart - Global Market by Application - Share by Year
    • 7.2.6. Chart - Global Market by Application - Segment Growth
  • 7.3. Global Market Organism-Overview
    • 7.3.1. Table - Global Market by Organism
    • 7.3.2. Chart - Global Market by Organism - Base/Final Year Comparison
    • 7.3.3. Chart - Global Market by Organism - Base Year
    • 7.3.4. Chart - Global Market by Organism - Final Year
    • 7.3.5. Chart - Global Market by Organism - Share by Year
    • 7.3.6. Chart - Global Market by Organism - Segment Growth

8. Global CRISPR Gene Detection and Diagnostics Markets - By Application

  • 8.1. Research
    • 8.1.1. Table Research - by Country
    • 8.1.2. Chart-Research Growth
  • 8.2. Clinical Laboratory
    • 8.2.1. Table Clinical Laboratory - by Country
    • 8.2.2. Chart-Clinical Laboratory Growth
  • 8.3. Clinical Consumer
    • 8.3.1. Table Clinical Consumer - by Country
    • 8.3.2. Chart-Clinical Consumer Growth
  • 8.4. Public Service
    • 8.4.1. Table Public Service - by Country
    • 8.4.2. Chart-Public Service Growth
  • 8.5. Agriculture/Other
    • 8.5.1. Table Agriculture/Other - by Country
    • 8.5.2. Chart - Agriculture/Other Growth

9. Global CRISPR Gene Detection and Diagnostics Markets - by Organism

  • 9.1. Human
    • 9.1.1. Table Human - by Country
    • 9.1.2. Chart-Human Growth
  • 9.2. Pathogen
    • 9.2.1. Table Pathogen - by Country
    • 9.2.2. Chart-Pathogen Growth
  • 9.3. Other Organism
    • 9.3.1. Table Other Organism - by Country
    • 9.3.2. Chart-Other Organism Growth

10. Appendices

  • 10.1. United States Medicare System: laboratory Fees Schedule
  • 10.2. The Most Used IVD Assays
  • 10.3. The Highest Grossing Assays
  • 10.4. The Whole Genome Sequence of SARS-CoV-2
  • 10.5. Global Listing of Sequencing Establishments - Location & Contacts

Table of Tables

  • Table 1: The Base Pairs
  • Table 2: CRISPR Assays Types & Times
  • Table 3: CRISPR Assays Readouts & Application
  • Table 4: The Base Pairs
  • Table 5: Market Players by Type
  • Table 6: The Different Markets for Genetic Detection
  • Table 7: Other Uses for CRISPR Gene Detection
  • Table 8: The Factors Driving Growth
  • Table 9: Factors Limiting Growth
  • Table 10: Global Market by Region
  • Table 11: Global Market by Application
  • Table 12: Global Market by Organism
  • Table 13: Research by Country
  • Table 14: Clinical Laboratory by Country
  • Table 15: Clinical Consumer by Country
  • Table 16: Public Service by Country
  • Table 17: Agriculture/Other by Country
  • Table 18: Human by Country
  • Table 19: Pathogen by Country
  • Table 20: Other Organism by Country
  • Table 21: Clinical Lab Fee Schedule
  • Table 22: The Most Common Assays
  • Table 23: Largest Revenue Assays
  • Table 24: List of Global Sequencing Locations

Table of Figures

  • Figure 1: DNA Strands and Chromosomes
  • Figure 2: Karyogram of Human Chromosomes
  • Figure 3: Size of Various Genomes
  • Figure 4: Global Healthcare Spending
  • Figure 5: The Lab Test Pie
  • Figure 6: The Road to Diagnostics
  • Figure 7: Cost To Sequence a Human Genome
  • Figure 8: Base Year Country Market Share Chart
  • Figure 9: Global Market by Application-Base vs. Final Year
  • Figure 10: Global Market by Application Base Year
  • Figure 11: Global Market by Application Final Year
  • Figure 12: Application Type Share by Year
  • Figure 13: by Application Segment Growth
  • Figure 14: by Organism - Base vs. Final Year
  • Figure 15: by Organism Market Base Year
  • Figure 16: by Organism Market Final Year
  • Figure 17: by Organism Share by Year
  • Figure 18: by Organism Segment Growth
  • Figure 19: Research Growth
  • Figure 20: Clinical Laboratory Growth
  • Figure 21: Clinical Consumer Growth
  • Figure 22: Public Service Growth
  • Figure 23: Agriculture/Other Growth
  • Figure 24: Human Growth
  • Figure 25: Pathogen Growth
  • Figure 26: Other Organism Growth